Skip to main content
Clinical Trials/NCT04108351
NCT04108351CompletedNot Applicable

Development and Validation of a Driving Simulator for Evaluating the Residual Effects of Drugs on Driving Performance - Sensitivity Analysis Using Zopiclone As a Positive Control

Taisho Pharmaceutical Co., Ltd.2 sites in 1 country28 target enrollmentStarted: October 7, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
28
Locations
2
Primary Endpoint
Standard Deviation of Lateral Position (SDLP)

Study Overview

Brief Summary

The purpose of this study is to confirm of assay sensitivity of Driving Simulator by positive control

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Other
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
21 Years to 64 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Body mass index (BMI) ≥18.5 and <25.0 kg/m^2 at screening inspection
  • •No visual impairment (enable to correct the vision with eyeglasses or contact lens)
  • •Receive a prior explanation on the study, able to accept its content, and capable to provide voluntary written consent for participation in this study
  • •Other protocol defined inclusion criteria could apply

Exclusion Criteria

  • •History of drug and food allergy
  • •Hypersensitivity to zopiclone
  • •Inappropriate for enrollment in this study was judged by principal investigator or subinvestigator
  • •Other protocol defined inclusion criteria could apply

Arms & Interventions

Zopiclone

Experimental

Intervention: Road-tracking test (Other)

Zopiclone

Experimental

Intervention: Car-following test (Other)

Zopiclone

Experimental

Intervention: Harsh-braking test (Other)

Placebo

Placebo Comparator

Intervention: Road-tracking test (Other)

Placebo

Placebo Comparator

Intervention: Car-following test (Other)

Placebo

Placebo Comparator

Intervention: Harsh-braking test (Other)

Outcomes

Primary Outcomes

Standard Deviation of Lateral Position (SDLP)

Time Frame: 60 min

Secondary Outcomes

  • Brake Reaction Time (BRT)(5 min)
  • Distance Coefficient of Variation (DCV)(5 min)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials